Yong-Kang Zhang

USPTO Granted Patents = 60 (Patent Applications = 26)

CIPO Patents = 4 (Patent Applications = 7)

EPO Patents = 12 (Patent Applications = 16)

Average Co-Inventor Count = 6.5

ph-index = 16

Forward Citations = 792(Granted Patents)

Forward Citations (Not Self Cited) = 580(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Santa Clara, CA (US) (1999 - 2002)
Moraga, CA (US) (2015 - 2017)
San Jose, CA (US) (2002 - 2023)
Cary, NC (US) (2021 - 2023)

Company Filing History:

37 out of 70

Anacor Pharmaceuticals, Inc.

patents

12 out of 35

Centaur Pharmaceuticals, Inc.

Eli Lilly and Company

patents

5. 2 out of 9

Bill & Melinda Gates Foundation

Mmv Medicines for Malaria Venture

patents

8. 1 out of 271

Johnson & Johnson Consumer Companies, Inc.

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

60 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12358932 - Chemical compounds (2025-07-15),

2. 12098159 - Solid forms of substituted benzoxaborole and compositions thereof (2024-09-24),

3. 11834466 - Benzoxaborole compounds and formulations thereof (2023-12-05),

4. 11578087 - Oxaborole esters and uses thereof (2023-02-14),

5. 11560393 - Solid forms of substituted benzoxaborole and compositions thereof (2023-01-24),

6. 11306108 - Chemical compounds (2022-04-19),

7. 11236115 - Solid forms of substituted benzoxaborole and compositions thereof (2022-02-01),

8. 11066424 - Solid forms of substituted benzoxaborole and compositions thereof (2021-07-20),

9. 10919916 - Boron-containing small molecules (2021-02-16),

10. 10882872 - Oxaborole esters and uses thereof (2021-01-05),

11. 10611780 - Boron-containing small molecules (2020-04-07),

12. 10562921 - Oxaborole esters and uses thereof (2020-02-18),

13. 10533021 - Boron-containing small molecules (2020-01-14),

14. 10011616 - Boron-containing small molecules as antiprotozoal1 agents (2018-07-03),

15. 9796735 - Boron-containing small molecules (2017-10-24),

Title: Innovations and Contributions of Yong-Kang Zhang

Introduction

Yong-Kang Zhang is a prolific inventor based in San Jose, CA, recognized for his innovative contributions in the field of pharmaceuticals. With an impressive portfolio of 59 patents, Zhang has made significant strides in advancing drug formulations and treatments that address various pathogens.

Latest Patents

His latest patents include groundbreaking work on solid forms of substituted benzoxaborole compounds. This invention discusses the crystalline forms of a specific compound and its applications in medical compositions. Another notable patent details a benzoxaborole formulation that combines a benzoxaborole compound with a mixture of surfactants and carriers. This formulation is designed to combat a range of pathogens, including insects, bacteria, and fungi, showcasing Zhang's commitment to addressing complex biological challenges.

Career Highlights

Zhang has held pivotal roles in recognized organizations, notably Anacor Pharmaceuticals and Centaur Pharmaceuticals. His work has been fundamental in the development of novel pharmaceuticals, contributing to improved therapies in the industry. His extensive patent portfolio highlights his expertise and innovative approach within the pharmaceutical sector.

Collaborations

Throughout his career, Zhang has collaborated with talented individuals such as Jacob J. Plattner and Tsutomu Akama. These partnerships have enriched his research and development efforts, fostering creativity and innovation in pharmaceutical sciences.

Conclusion

Yong-Kang Zhang’s contributions to the field of patents and innovations in drug formulations demonstrate the significant impact of dedicated inventors. His work continues to play a crucial role in advancing medical treatments, reflecting his commitment to innovation and excellence in research.

This text is generated by artificial intelligence and may not be accurate.